Physiotherapy is fastest growing segment fueling the growth of Sciatica Market
The global Sciatica Market is estimated to be valued at US$ 6962.2 Mn or Mn in 2023 and is expected to exhibit a CAGR of 5.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Sciatica refers to leg pain caused by compressed, damaged, or irritated lumbar or sacral nerve roots in the back. It usually occurs on one side of the body and radiates from lower back through the hips and buttocks and down one leg. Sciatica is commonly caused by herniated disc, arthritis, tight muscles, and other issues affecting the back and hips. Physiotherapy plays an important role in the management of sciatica without surgery via techniques like spinal manipulation, thermotheraphy, and overall wellness management.
Market key trends:
One of the major trends in the sciatica market is increasing cases of herniated disc and spinal stenosis. Herniated discs and spinal stenosis are the most common causes of sciatica. Factors such as sedentary lifestyle, lack of physical activity, heavy weight lifting, and growing aging population are key contributors to the rising prevalence of disc issues and spinal stenosis, thus fueling the growth of sciatica treatment market. According to National Institute of Neurological Disorders and Stroke, about 40% of adults experience low back pain at some point in their lives which often radiates down the leg as sciatica. As low back issues continue to rise globally, demand for effective sciatica drugs and therapy is expected to propel over the forecast period.
Segment Analysis
The global sciatica market is segmented into treatment type, route of administration, and distribution channel. Based on treatment type, the market is segmented into medication, physical therapy, surgery, and others. The medication segment dominated the market in 2023 as it is the most common initial treatment for sciatica and involves over-the-counter or prescription painkillers. The physical therapy segment is expected to witness high growth during the forecast period due to rising focus on non-drug therapies for sciatica treatment.
Key Takeaways
The global sciatica market size was valued at US$ 6962.2 Mn in 2023 and is expected to witness high growth, exhibiting a CAGR of 5.1% over the forecast period, due to the increasing geriatric population who are more prone to sciatica and rising obesity rates which is a major cause of sciatica.
Regional analysis - North America dominated the global market in 2023 due to high healthcare expenditure and increasing prevalence of sciatica in the region. Asia Pacific is expected to witness fastest growth during the forecast period owing to growing cases of spinal disorders and rising healthcare expenditure in emerging countries of the region.
Key players - Key players operating in the sciatica market are Sorrento Therapeutics, Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Zydus Cadila, Glenmark Pharmaceuticals Ltd., Amneal Pharmaceuticals LLC, Jubilant Life Sciences Ltd., Hikma Pharmaceuticals PLC., Mylan N.V., Horizon Therapeutics Plc., Sun Pharmaceutical Industries Ltd., Alkem Labs, SCILEX Pharmaceuticals, Inc., Seikagaku Corporation, Kolon Life Science, Inc., Teijin Limited, and SpineThera, Inc. The major players are focused on developing innovative treatment options to strengthen their market position.

Comments
Post a Comment